blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3481864

EP3481864 - ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.05.2024
Database last updated on 22.08.2024
FormerExamination is in progress
Status updated on  10.07.2020
FormerRequest for examination was made
Status updated on  12.04.2019
FormerThe international publication has been made
Status updated on  12.01.2018
Formerunknown
Status updated on  09.08.2017
Most recent event   Tooltip17.05.2024Application deemed to be withdrawnpublished on 19.06.2024  [2024/25]
Applicant(s)For all designated states
Staten Biotechnology B.V.
Transistorweg 5J
6534 AT Nijmegen / NL
[2019/20]
Inventor(s)01 / DASILVA-JARDINE, Paul
160 Sam Hill Road
Gilford, Connecticut 06437 / US
02 / DE HAARD, Hans
't Zwint 1
NL-4436 NA Oudelande / NL
03 / LANDRO, James A.
412 Maple Avenue
Cheshire, Connecticut 06410 / US
 [2019/20]
Representative(s)Simmons & Simmons LLP (Munich), et al
Lehel Carré
Thierschplatz 6
80538 Munich / DE
[N/P]
Former [2019/20]Lahrtz, Fritz
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Prinzregentenstraße 68
81675 München / DE
Application number, filing date17745513.607.07.2017
[2019/20]
WO2017IB54125
Priority number, dateUS201662360084P08.07.2016         Original published format: US 201662360084 P
US201762491591P28.04.2017         Original published format: US 201762491591 P
[2019/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018007999
Date:11.01.2018
Language:EN
[2018/02]
Type: A1 Application with search report 
No.:EP3481864
Date:15.05.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 11.01.2018 takes the place of the publication of the European patent application.
[2019/20]
Search report(s)International search report - published on:EP11.01.2018
(Supplementary) European search report - dispatched on:EP14.07.2020
ClassificationIPC:C07K16/18, A61K39/395, A61P3/06
[2019/20]
CPC:
C07K16/18 (EP,KR,US); A61K39/3955 (US); A61K31/397 (EP,US);
A61K45/06 (KR,US); A61P3/06 (EP,KR,US); A61P9/00 (KR);
A61P9/10 (EP,KR,US); C12N15/63 (US); C12N5/00 (US);
A61K2039/505 (EP,KR,US); C07K14/775 (US); C07K2317/22 (EP,KR,US);
C07K2317/24 (US); C07K2317/33 (EP,KR,US); C07K2317/34 (EP,KR,US);
C07K2317/51 (US); C07K2317/56 (US); C07K2317/565 (US);
C07K2317/622 (EP,KR,US); C07K2317/76 (EP,KR,US); C07K2317/92 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/20]
Extension statesBA07.02.2019
ME07.02.2019
Validation statesMA07.02.2019
MD07.02.2019
TitleGerman:ANTI-APOC3-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON[2019/20]
English:ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF[2019/20]
French:ANTICORPS ANTI-APOC3 ET LEURS MÉTHODES D'UTILISATION[2019/20]
Entry into regional phase07.02.2019National basic fee paid 
07.02.2019Designation fee(s) paid 
07.02.2019Examination fee paid 
Examination procedure07.02.2019Examination requested  [2019/20]
07.02.2019Date on which the examining division has become responsible
29.08.2019Amendment by applicant (claims and/or description)
14.07.2020Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M08) [2020/33]
14.07.2020Despatch of a communication from the examining division (Time limit: M08)
30.06.2021Reply to a communication from the examining division
23.12.2021Despatch of a communication from the examining division (Time limit: M04)
13.04.2022Reply to a communication from the examining division
01.02.2024Application deemed to be withdrawn, date of legal effect  [2024/25]
21.02.2024Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/25]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
30.06.2021Request for further processing filed
30.06.2021Full payment received (date of receipt of payment)
Request granted
12.07.2021Decision despatched
Fees paidRenewal fee
15.07.2019Renewal fee patent year 03
14.07.2020Renewal fee patent year 04
27.07.2021Renewal fee patent year 05
27.07.2022Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.07.202307   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO2004081046  (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [X] 1-5 * page 7, line 5 - line 16 * * page 15, line 13 - line 25 * [I] 6,7,41-64;
 [A]WO2004097429  (BIOSTRATUM INC [US], et al) [A] 1-7,41-64* page 8, line 13 - line 32; claim 5 *;
 [XI]WO2014131008  (INTRINSIC METABIO SOLUTIONS LLC [US]) [X] 1-5 * examples 1,2 * * page 1, line 15 - line 23 * [I] 6,7,41-64
by applicantUS4044126
 US4364923
 US4414209
 US4444887
 WO8605807
 EP0239400
 US4716111
 WO8901036
 US4816567
 US4816397
 WO9002809
 WO9109967
 WO9110737
 WO9110741
 WO9201047
 US5122464
 WO9218619
 WO9222324
 EP0519596
 WO9311236
 US5223409
 US5225539
 WO9317105
 WO9404678
 EP0592106
 WO9425591
 US5403484
 US5413923
 WO9515982
 US5427908
 WO9520401
 US5516637
 US5530101
 US5545806
 US5565332
 US5569825
 WO9634096
 WO9633735
 US5571698
 US5580717
 US5585089
 WO9713844
 US5625126
 US5633425
 US5658727
 US5661016
 US5698426
 US5709874
 US5733743
 WO9816654
 US5750753
 US5759542
 WO9824893
 US5766886
 US5780225
 US5807715
 US5814318
 US5821047
 WO9846645
 WO9850433
 US5837242
 US5840674
 US5860957
 US5869620
 US5885793
 US5900252
 US5939598
 US5948433
 US5965726
 US5969108
 US5972366
 US5983134
 US5985317
 US5985307
 US5989830
 US6004534
 US6005079
 US6010715
 US6024975
 US6039975
 US6048736
 US6060082
 US6071495
 US6075181
 US6120751
 US6131570
 US6132992
 US6139865
 US6150184
 US6167301
 US6174666
 WO0144301
 US6256533
 US6253872
 US6261595
 US6267983
 US6271359
 US6274552
 US6291664
 US6316652
 US6331415
 US6407213
 US6414132
 US6794498
 US2005042664
 US2005048549
 US7183076
 US7709226
 US7951917
 US8227577
 US8586713
    - KABAT et al., J. Biol. Chem., (19770000), vol. 252, pages 6609 - 6616
    - CHOTHIA et al., J. Mol. Biol., (19870000), vol. 196, pages 901 - 917
    - MACCALLUM et al., J. Mol. Biol., (19960000), vol. 262, pages 732 - 745
    - CHOTHIA C; LESK AM, J Mol Biol, (19870000), vol. 196, pages 901 - 917
    - AL-LAZIKANI B et al., J Mol Biol, (19970000), vol. 273, pages 927 - 948
    - CHOTHIA C et al., J Mol Biol, (19920000), vol. 227, pages 799 - 817
    - TRAMONTANO A et al., J Mol Biol, (19900000), vol. 215, no. 1, pages 175 - 182
    - LEFRANC M-P, The Immunologist, (19990000), vol. 7, pages 132 - 136
    - LEFRANC M-P et al., Nucleic Acids Res, (19990000), vol. 27, pages 209 - 212
    - MACCALLUM RM et al., J Mol Biol, (19960000), vol. 262, pages 732 - 745
    - "Protein Sequence and Structure Analysis of Antibody Variable Domains", MARTIN A., Antibody Engineering, Springer-Verlag, (20010000), pages 422 - 439
    - STAHLI C et al., Methods Enzymol, (19830000), vol. 9, pages 242 - 253
    - KIRKLAND TN et al., J Immunol, (19860000), vol. 137, pages 3614 - 3619
    - MOREL GA et al., Mol Immunol, (19880000), vol. 25, no. 1, pages 7 - 15
    - CHEUNG RC et al., Virology, (19900000), vol. 176, pages 546 - 552
    - MOLDENHAUER G et al., Scand J Immunol, (19900000), vol. 32, pages 77 - 82
    - WAGENER C et al., J Immunol, (19830000), vol. 130, pages 2308 - 2315
    - WAGENER C et al., J Immunol Methods, (19840000), vol. 68, pages 269 - 274
    - KUROKI M et al., Cancer Res, (19900000), vol. 50, pages 4872 - 4879
    - KUROKI M et al., Immunol Invest, (19920000), vol. 21, pages 523 - 538
    - KUROKI M et al., Hybridoma, (19920000), vol. 11, pages 391 - 407
    - Antibodies: A Laboratory Manual, pages 386 - 389
    - KUTMEIER G et al., BioTechniques, (19940000), vol. 17, pages 242 - 246
    - Current Protocols in Molecular Biology, Green Publishing Associates, Inc. and John Wiley & Sons, Inc., (19890000), vol. I, pages 6.3.1 - 6.3.6,2.10.3
    - FOECKING MK; HOFSTETTER H, Gene, (19860000), vol. 45, pages 101 - 105
    - COCKETT MI et al., Biotechnology, (19900000), vol. 8, no. 7, pages 662 - 667
    - RUETHER U; MUELLER-HILL B, EMBO J, (19830000), vol. 2, pages 1791 - 1794
    - INOUYE S; INOUYE M, Nuc Acids Res, (19850000), vol. 13, pages 3101 - 3109
    - VAN HEEKE G; SCHUSTER SM, J Biol Chem, (19890000), vol. 24, pages 5503 - 5509
    - LOGAN J; SHENK T, PNAS, (19840000), vol. 81, no. 12, pages 3655 - 3659
    - BITTER G et al., Methods Enzymol., (19870000), vol. 153, pages 516 - 544
    - WIGLER M et al., Cell, (19770000), vol. 11, no. 1, pages 223 - 232
    - SZYBALSKA EH; SZYBALSKI W, PNAS, (19620000), vol. 48, no. 12, pages 2026 - 2034
    - LOWY I et al., Cell, (19800000), vol. 22, no. 3, pages 817 - 823
    - WIGLER M et al., PNAS, (19800000), vol. 77, no. 6, pages 3567 - 3570
    - O'HARE K et al., PNAS, (19810000), vol. 78, pages 1527 - 1531
    - MULLIGAN RC; BERG P, PNAS, (19810000), vol. 78, no. 4, pages 2072 - 2076
    - WU GY; WU CH, Biotherapy, (19910000), vol. 3, pages 87 - 95
    - TOLSTOSHEV P, Ann Rev Pharmacol Toxicol, (19930000), vol. 32, pages 573 - 596
    - MULLIGAN RC, Science, (19930000), vol. 260, pages 926 - 932
    - MORGAN RA; ANDERSON WF, Ann Rev Biochem, (19930000), vol. 62, pages 191 - 217
    - NABEL GJ; FEIGNER PL, Trends Biotechnol, (19930000), vol. 11, no. 5, pages 211 - 215
    - SANTERRE RF et al., Gene, (19840000), vol. 30, no. 1-3, pages 147 - 156
    - COLBERE-GARAPIN F et al., J Mol Biol, (19810000), vol. 150, pages 1 - 14
    - BEBBINGTON CR; HENTSCHEL CCG, The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells in DNA cloning, Academic Press, (19870000), vol. 3
    - CROUSE GF et al., Mol Cell Biol, (19830000), vol. 3, pages 257 - 266
    - PROUDFOOT NJ, Nature, (19860000), vol. 322, pages 562 - 565
    - KOHLER G, PNAS, (19800000), vol. 77, pages 2197 - 2199
    - HAMMERLING GJ et al., Monoclonal Antibodies and T-Cell Hybridomas, Elsevier, (19810000), pages 563 - 681
    - KOHLER G; MILSTEIN C, Nature, (19750000), vol. 256, page 495
    - Monoclonal Antibodies: Principles and Practice, Academic Press, (19860000), pages 59 - 103
    - KILPATRICK KE et al., Hybridoma, (19970000), vol. 16, pages 381 - 389
    - KOZBOR D, J Immunol, (19840000), vol. 133, pages 3001 - 3005
    - BRODEUR et al., Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., (19870000), pages 51 - 63
    - Monoclonal Antibodies: Principles and Practice
    - BRINKMAN U et al., J Immunol Methods, (19950000), vol. 182, pages 41 - 50
    - AMES RS et al., J Immunol Methods, (19950000), vol. 184, pages 177 - 186
    - KETTLEBOROUGH CA et al., Eur J Immunol, (19940000), vol. 24, pages 952 - 958
    - PERSIC L et al., Gene, (19970000), vol. 187, pages 9 - 18
    - BURTON DR; BARBAS CF, Advan Immunol, (19940000), vol. 57, pages 191 - 280
    - MULLINAX RL et al., BioTechniques, (19920000), vol. 12, no. 6, pages 864 - 869
    - SAWAI H et al., Am J Reprod Immunol, (19950000), vol. 34, pages 26 - 34
    - BETTER M et al., Science, (19880000), vol. 240, pages 1041 - 1043
    - MORRISON SL, Science, (19850000), vol. 229, pages 1202 - 1207
    - OI VT; MORRISON SL, BioTechniques, (19860000), vol. 4, pages 214 - 221
    - GILLIES SD et al., J Immunol Methods, (19890000), vol. 125, pages 191 - 202
    - PADLAN EA, Mol Immunol, (19910000), vol. 28, no. 4/5, pages 489 - 498
    - STUDNICKA GM et al., Prot Engineering, (19940000), vol. 7, no. 6, pages 805 - 814
    - ROGUSKA MA et al., PNAS, (19940000), vol. 91, pages 969 - 973
    - TAN P et al., J Immunol, (20020000), vol. 169, pages 1119 - 1125
    - CALDAS C et al., Protein Eng., (20000000), vol. 13, no. 5, pages 353 - 360
    - MOREA V et al., Methods, (20000000), vol. 20, no. 3, pages 267 - 279
    - BACA M et al., J Biol Chem, (19970000), vol. 272, no. 16, pages 10678 - 10684
    - ROGUSKA MA et al., Protein Eng, (19960000), vol. 9, no. 10, pages 895 - 904
    - COUTO JR et al., Cancer Res., (19950000), vol. 55, no. 23, pages 5973s - 5977s
    - COUTO JR et al., Cancer Res, (19950000), vol. 55, no. 8, pages 1717 - 1722
    - SANDHU JS, Gene, (19940000), vol. 150, no. 2, pages 409 - 410
    - PEDERSEN JT et al., J Mol Biol, (19940000), vol. 235, no. 3, pages 959 - 973
    - RIECHMANN L; MUYLDERMANS S, J Immunol, (19990000), vol. 231, pages 25 - 38
    - NUTTALL SD et al., Curr Pharm Biotechnol, (20000000), vol. 1, no. 3, pages 253 - 263
    - MUYLDERMANS S, J Biotechnol, (20010000), vol. 74, no. 4, pages 277 - 302
    - GREENSPAN NS; BONA CA, FASEB J, (19890000), vol. 7, no. 5, pages 437 - 444
    - NISSINOFF A, J Immunol, (19910000), vol. 147, no. 8, pages 2429 - 2438
    - LONBERG N; HUSZAR D, Int Rev Immunol, (19950000), vol. 13, pages 65 - 93
    - SHINMOTO H et al., Cytotechnology, (20040000), vol. 46, pages 19 - 23
    - NAGANAWA Y et al., Human Antibodies, (20050000), vol. 14, pages 27 - 31
    - KLARENBEEK et al., Protein Eng Des Sel, (20160000), vol. 29, no. 4, pages 123 - 133
    - VAN DER WONING et al., "DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops", mAbs, (20160000), vol. 8, no. 6, pages 1126 - 1135
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.